K250816

Substantially Equivalent

ADVIA Centaur Anti-Thyroglobulin II (aTgII)

Applicant: Siemens Healthcare Diagnostics, Inc.
Product code: JNL
Advisory panel: Immunology
Date received: 2025-03-18
Decision date: 2025-12-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Tarrytown, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.